Latest Articles

Publication Date
The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy.

Cancer treatments can deplete the ovarian follicle reserve, causing infertility and early menopause, with subsequent decline in cardiovascular, cognitive, and overall women's health. Medical measures to prevent this chemotherapy-induced ovarian …

Published: June 20, 2026, midnight
ZNF143 Promotes Endometriotic Lesion Growth and Fibrosis through the Plasminogen Activator Inhibitor-1 Pathway.

Endometriosis (EMs) is a chronic, estrogen-dependent gynecological disorder characterized by the ectopic growth of endometrial tissue outside the uterus. Zinc Finger Protein 143 (ZNF143) is a DNA-binding transcription factor, yet …

Published: June 18, 2026, midnight
PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer - Medscape Reference

PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer Medscape Reference

Published: June 17, 2026, 2:51 p.m.
p16 Beyond Senescence: Cancer Biology Lessons Applied to Endometriosis.

Endometriosis is an estrogen-dependent disease characterized by chronic inflammation and fibrosis and is a major cause of pelvic pain and infertility. Recent studies have reported dysregulated expression of p16INK4a, a …

Published: June 11, 2026, midnight
Identification of BAY-439 - A Selective Human Phospholipase A2 Group V Inhibitor - Evotec

Identification of BAY-439 - A Selective Human Phospholipase A2 Group V Inhibitor Evotec

Published: June 5, 2026, 1:36 p.m.
SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease.

Rheumatic heart disease (RHD) remains a major cause of cardiovascular morbidity and premature mortality among children and young adults, particularly in low- and middle-income countries. Current management relies on antibiotic …

Published: June 4, 2026, midnight
Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis.

Endometriosis is a common gynecologic disorder often associated with chronic pelvic pain, infertility, and reduced quality of life. Conventional imaging modalities, such as transvaginal ultrasound and MRI, may underestimate the …

Published: June 4, 2026, midnight
Optimizing Biomarker-Driven Treatment and Immune Checkpoint Inhibitor Counseling in Endometrial Cancer - Pharmacy Times

Optimizing Biomarker-Driven Treatment and Immune Checkpoint Inhibitor Counseling in Endometrial Cancer Pharmacy Times

Published: May 28, 2026, 8:50 p.m.
Biomarker Testing and Immune Checkpoint Inhibitor Counseling Shape Endometrial Cancer Care - Pharmacy Times

Biomarker Testing and Immune Checkpoint Inhibitor Counseling Shape Endometrial Cancer Care Pharmacy Times

Published: May 27, 2026, 4:12 p.m.
Immune Checkpoint Inhibitors Transform Frontline Endometrial Cancer Care - Pharmacy Times

Immune Checkpoint Inhibitors Transform Frontline Endometrial Cancer Care Pharmacy Times

Published: May 26, 2026, 3:57 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!